Ex vivo assessment of chemotherapy-induced apoptosis and associated molecular changes in patient tumor samples.

Background: There are inherent conceptual problems in investigating the pharmacodynamics of cancer drugs in vivo. One of the few possible approaches is serial biopsies in patients. However, this type of research is severely limited by methodological and ethical constraints.